Alkermes plc. EV/EBIT ALKS

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Oct 23, 2026: 69.6×
3-year median: 11.9×
Against its 3-year history: 95th; percentile: 0 is its lowest day, 100 its highest
3-year range: 7.4× to 77.6×
Peer median: 54.6×

Alkermes plc.'s EV/EBIT is 69.6× as of Oct 23, 2026.

That is above its 3-year median of 11.9×, higher than on 95% of days in the last 3 years.

Over that time it ranged from 7.4× in May 2024 to 77.6× in Aug 2026.

The median for 10 large drugmakers of a similar size is 54.6×.

EV/EBIT over time

median 11.9×

The dashed line is the 3-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	69.6×	10.1×	77.6×
2025	10.2×	8.8×	14.4×
2024	13.3×	7.4×	14.3×
2023	11.7×	9.8×	23.2×
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	n/m a value too high to mean anything
2019	n/m a value too high to mean anything
2018	n/m a value too high to mean anything
2017	n/m a value too high to mean anything
2016	n/m a value too high to mean anything
2015	n/m a value too high to mean anything
2014	n/m a value too high to mean anything
2013	85.4×	57.5×	151×
2012	126×	126×	137×

Against its peers

Companies in Drug Manufacturers - General nearest Alkermes plc.'s size, closest first, today.

Company	EV/EBIT
ALKSAlkermes plc.	69.6×
AMRXAmneal Pharmaceuticals	18.3×
TGTXTG Therapeutics	62.2×
LGNDLigand Pharmaceuticals	57.7×
KNSAKiniksa Pharmaceuticals International	54.6×
PTGXProtagonist Therapeutics	140×
CORTCorcept Therapeutics	n/m
BMRNBiomarin Pharmaceutical	25.8×
INDVIndivior Pharmaceuticals	7.8×
ARQTArcutis Biotherapeutics	111×
JAZZJazz Pharmaceuticals	15.9×
Peer median	54.6×

Where Alkermes plc. ranks

#45of 48Large drugmakers with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Alkermes plc.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.